scholarly journals Drug‐induced increase in lysobisphosphatidic acid reduces the cholesterol overload in Niemann–Pick type C cells and mice

EMBO Reports ◽  
2019 ◽  
Vol 20 (7) ◽  
Author(s):  
Dimitri Moreau ◽  
Fabrizio Vacca ◽  
Stefania Vossio ◽  
Cameron Scott ◽  
Alexandria Colaco ◽  
...  
2018 ◽  
Author(s):  
Dimitri Moreau ◽  
Fabrizio Vacca ◽  
Stefania Vossio ◽  
Cameron Scott ◽  
Alexandria Colaco ◽  
...  

ABSTRACTMost cells acquire cholesterol by endocytosis of circulating LDLs. After cholesteryl ester de-esterification in endosomes, free cholesterol is redistributed to intracellular membranes via unclear mechanisms. Our previous work suggested that the unconventional phospholipid lysobisphosphatidic acid (LBPA) may play a role in modulating the cholesterol flux through endosomes. In this study, we used the Prestwick library of FDA-approved compounds in a high content, image-based screen of the endosomal lipids, lysobisphosphatidic acid and LDL-derived cholesterol. We report that thioperamide maleate, an inverse agonist of the histamine H3 receptor HRH3, increases highly selectively the levels of lysobisphosphatidic acid, without affecting any endosomal protein or function that we tested. Our data also show that thioperamide significantly reduces the endosome cholesterol overload in fibroblasts from patients with the cholesterol storage disorder Niemann-Pick type C (NPC), as well as in liver ofNpc1−/−mice. We conclude that LBPA controls endosomal cholesterol mobilization and export to cellular destinations, perhaps by fluidifying or buffering cholesterol in endosomal membranes, and that thioperamide has repurposing potential for the treatment of NPC.


2000 ◽  
Vol 275 (23) ◽  
pp. 17468-17475 ◽  
Author(s):  
Yvonne Lange ◽  
Jin Ye ◽  
Mike Rigney ◽  
Theodore Steck
Keyword(s):  
C Cells ◽  
Type C ◽  

2010 ◽  
Vol 8 (3) ◽  
pp. 295-319 ◽  
Author(s):  
Shilpi Arora ◽  
Christian Beaudry ◽  
Kristen M. Bisanz ◽  
Chao Sima ◽  
Jeffrey A. Kiefer ◽  
...  

2000 ◽  
Vol 11 (5) ◽  
pp. 1829-1843 ◽  
Author(s):  
Toshihide Kobayashi ◽  
Ulrich M. Vischer ◽  
Corinne Rosnoblet ◽  
Cécile Lebrand ◽  
Margaret Lindsay ◽  
...  

In the present study, we show that in human endothelial cells the tetraspanin CD63/lamp3 distributes predominantly to the internal membranes of multivesicular–multilamellar late endosomes, which contain the unique lipid lysobisphosphatidic acid. Some CD63/lamp3 is also present in Weibel–Palade bodies, the characteristic secretory organelle of these cells. We find that CD63/lamp3 molecules can be transported from late endosomes to Weibel–Palade bodies and thus that CD63/lamp3 cycles between endocytic and biosynthetic compartments; however, movement of CD63/lamp3 is much slower than that of P-selectin, which is known to cycle between plasma membrane and Weibel–Palade bodies. When cells are treated with U18666A, a drug that mimics the Niemann-Pick type C syndrome, both proteins accumulate in late endosomes and fail to reach Weibel–Palade bodies efficiently, suggesting that P-selectin, like CD63/lamp3, cycles via late endosomes. Our data suggest that CD63/lamp3 partitions preferentially within late endosome internal membranes, thus causing its accumulation, and that this mechanism contributes to CD63/lamp3 retention in late endosomes; however, our data also indicate that the protein can eventually escape from these internal membranes and recycle toward Weibel–Palade bodies to be reused. Our observations thus uncover the existence of a selective trafficking route from late endosomes to Weibel–Palade bodies.


2009 ◽  
Vol 106 (46) ◽  
pp. 19316-19321 ◽  
Author(s):  
L. Abi-Mosleh ◽  
R. E. Infante ◽  
A. Radhakrishnan ◽  
J. L. Goldstein ◽  
M. S. Brown

2013 ◽  
Vol 110 (25) ◽  
pp. 10207-10212 ◽  
Author(s):  
N. E. Mbua ◽  
H. Flanagan-Steet ◽  
S. Johnson ◽  
M. A. Wolfert ◽  
G.-J. Boons ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document